---
# Documentation: https://wowchemy.com/docs/managing-content/

title: 'Allergic reactions to the first COVID-19 vaccine: a potential role of Polyethylene
  glycol?'
subtitle: ''
summary: ''
authors:
- Beatriz Cabanillas
- Cezmi Akdis
- Natalija Novak
tags:
- '"COVID-19"'
- '"SARS-CoV-2"'
- '"BNT162b2"'
- '"Polyethylene glycol"'
- '"Vaccine"'
categories: []
date: -01-01
lastmod: 2021-03-21T12:36:24+01:00
featured: false
draft: false

# Featured image
# To use, add an image named `featured.jpg/png` to your page's folder.
# Focal points: Smart, Center, TopLeft, Top, TopRight, Left, Right, BottomLeft, Bottom, BottomRight.
image:
  caption: ''
  focal_point: ''
  preview_only: false

# Projects (optional).
#   Associate this post with one or more of your projects.
#   Simply enter your project's folder or file name without extension.
#   E.g. `projects = ["internal-project"]` references `content/project/deep-learning/index.md`.
#   Otherwise, set `projects = []`.
projects: []
publishDate: '2021-03-29T11:55:26.885394Z'
publication_types:
- '2'
abstract: The COVID-19 vaccine developed by Pfizer and BioNTech was approved by the
  Medicines and Healthcare Products Regulatory Agency (MHRA) in the United Kingdom
  (UK) on December 2nd 2020.1 MHRA is therefore the first regulator agency in the
  world to approve a vaccine to prevent coronavirus disease (COVID-19), which is caused
  by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus that is
  responsible for a global pandemic.
publication: '*Allergy*'
url_pdf: https://onlinelibrary.wiley.com/doi/abs/10.1111/all.14711
doi: https://doi.org/10.1111/all.14711
---
